Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Genus Lifesciences

NDC labeler code: 64950

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

7Products (NDC)

Prescription medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
November 5, 2024ANDA217887 Ciprofloxacin
CIPROFLOXACIN HYDROCHLORIDE
Alembic Therap
December 22, 2014NDA206814 Potassium chloride
POKONZA, POTASSIUM CHLORIDE
Genus Lifesciences
May 31, 1995ANDA074431 Flurbiprofen
FLURBIPROFEN
Genus
June 30, 1994ANDA073399 Clemastine fumarate
CLEMASTINE FUMARATE
Genus
January 31, 1992ANDA073283 Clemastine fumarate
CLEMASTINE FUMARATE
Genus
August 24, 1972ANDA080936 Isoniazid
ISONIAZID
Genus Lifesciences
August 24, 1972ANDA080937 Isoniazid
ISONIAZID
Genus Lifesciences

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2020

  1. December 23, 2020 · Class III · Terminated · D-0231-2021 · Oxycodone hydrochloride

    Presence of Foreign Substance: Particulate matter was found in multiple lots of product.

    Oxycodone Hydrochloride Oral Solution, USP 5 mg/5mL unit dose cups, Rx Only, Genus Lifesciences Inc. NDC 64950-354-05 Case NDC: 64950-354-450(40 unit dose cups) Case NDC 64950-354-55 (50 unit dose cups)

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →